Ronkonkoma, New York (PressExposure) January 31, 2012 -- inGenious Targeting Laboratory (iTL), a leader in the industry of genetically modified mice, announces the relocation of their world headquarters to a new facility in Ronkonkoma, NY. The move, in response to an expanding staff and increasing technical demands, will allow iTL to provide its employees with additional space and tools to address their client's evolving research needs.
"The new laboratory will provide iTL with the room to accommodate an increasing client base. It will also give us the capacity to broaden the scope of the technology used to address new, and potential challenges in the strategy design and execution of customized gene targeted mouse models," said iTL's President and COO Paul Sheiffele. "We are delighted to move into this new space, and are excited to be a part of the growing life science community in the area."
The new headquarters, located at 2200 Smithtown Ave, Ronkonkoma, NY is surrounded by world-class research facilities such as, Stony Brook University, Cold Spring Harbor and Brookhaven National Laboratory; institutions which iTL has shared long-standing relationships with.
About inGenious Targeting Laboratory
inGenious Targeting Laboratory, Inc (iTL) was founded in 1998, and is a global provider of gene targeting and custom mouse model production and services. iTL has delivered over eleven hundred successful custom mouse models to investigators worldwide. iTL is dedicated exclusively to the generation of customized gene targeted mouse models for the research community including researchers in academic and medical institutes, government research centers, and pharmaceutical and biotechnology companies. Clients retain full intellectual property rights to their projects. A full range of project capabilities are available including conventional knockout, conditional knockout, knockin, reporter genes, knockin human/murine cDNAs, targeted transgenic models, as well as novel approaches for custom models. Full-service customer projects are initiated immediately upon completion of design parameters and progress to completion on-site. For more information, including publication list and quote request, please visit http://www.genetargeting.com